Search details
1.
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.
Haematologica
; 108(9): 2444-2453, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-36815381
2.
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
Eur J Haematol
; 110(4): 386-395, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36539351
3.
Insights into dasatinib use and outcomes in real-world patients with chronic myeloid leukemia.
Haematologica
; 108(8): 2224-2228, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-36655426
4.
The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers.
Support Care Cancer
; 25(11): 3447-3456, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28667564
5.
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
J Clin Oncol
; : JCO2301655, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38531001
6.
Alcohol and tobacco use and risk of multiple myeloma: A case-control study.
EJHaem
; 3(1): 109-120, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35846225
7.
Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study.
JNCI Cancer Spectr
; 5(1)2021 02.
Article
in English
| MEDLINE | ID: mdl-33442664
8.
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Cancer Res
; 78(14): 4086-4096, 2018 07 15.
Article
in English
| MEDLINE | ID: mdl-29735552
9.
The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period.
J Cancer Surviv
; 11(3): 329-338, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28144891
10.
2â+â2 in the long term: informing a new standard of care in 2021 for early stage, unfavourable Hodgkin lymphoma.
Lancet Haematol
; 8(4): e243-e245, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33770475
11.
Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma.
Leuk Lymphoma
; 54(7): 1465-72, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23121086
Results
1 -
11
de 11
1
Next >
>>